# FDA 483 - Charles Parker, M.D. - January 18, 2019

Source: https://www.globalkeysolutions.net/records/483/charles-parker-md/23611781-df20-4546-a381-c3117c9b36e9

> FDA 483 for Charles Parker, M.D. on January 18, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Charles Parker, M.D.
- Inspection Date: 2019-01-18
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Charles J. Parker, M.D., a clinical investigator in Salt Lake City, UT, revealed significant deviations from investigational plans. The firm failed to properly evaluate subjects against all screening criteria before administering investigational study drugs and did not adhere to protocol requirements for pre-drug administration exams. These findings indicate a lack of adherence to study protocols.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/stephen-t-hansen/7ae1f1df-7f68-4264-bd87-ea21c8d879bb)

Company: https://www.globalkeysolutions.net/companies/charles-parker-md/c9ef4095-6a19-4ffe-bc5a-5c094b4ee286

Office: https://www.globalkeysolutions.net/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face